Minutes of the HMPC meeting 22-24 July 2024
Submitted by Anonymous (not verified) on 7 October 2024 - 10:00
Minutes of the HMPC meeting 22-24 July 2024
Medical devices
Submitted by Anonymous (not verified) on 7 October 2024 - 8:49
Medical devices
Management Board meeting: 3 October 2024, European Medicines Agency, Amsterdam, the Netherlands, 3 October 2024
Submitted by Anonymous (not verified) on 7 October 2024 - 8:45
Management Board meeting: 3 October 2024, European Medicines Agency, Amsterdam, the Netherlands, 3 October 2024
Outcome of written procedures finalised during the period from 04 June 2024 to 25 September 2024
Submitted by Anonymous (not verified) on 7 October 2024 - 8:43
Outcome of written procedures finalised during the period from 04 June 2024 to 25 September 2024
Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0341/2023
Submitted by Anonymous (not verified) on 7 October 2024 - 8:30
Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastroentology-Hepatology, PIP number: P/0341/2023
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Status: Authorised
Submitted by Anonymous (not verified) on 7 October 2024 - 8:28
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Status: Authorised
EMEA-003319-PIP02-22
Submitted by Anonymous (not verified) on 7 October 2024 - 8:00
EMEA-003319-PIP02-22
EMEA-003319-PIP03-22
Submitted by Anonymous (not verified) on 7 October 2024 - 8:00
EMEA-003319-PIP03-22
EMEA-003326-PIP01-22
Submitted by Anonymous (not verified) on 7 October 2024 - 8:00
EMEA-003326-PIP01-22
EMEA-003328-PIP01-22
Submitted by Anonymous (not verified) on 7 October 2024 - 7:56
EMEA-003328-PIP01-22